This is Glenmark’s first granted CGT product approved by the FDA.
Share price of Glenmark pharma accessorial nearly 4.8 % intraday Mon when USFDA final approval for hydrocortisone Valerate Ointment USP.
Glenmark pharmaceuticals inc., USA has been granted final approval by the u. s. Food & Drug Administration (USFDA) for hydrocortisone Valerate Ointment USP, 0.2%, a generic version of Westcort Ointment, 0.2%, of Sun Pharmaceutical Industries, Inc.
Glenmark has been granted a competitive generic medical care (CGT) designation for hydrocortisone Valerate Ointment, therefore, with this approval, Glenmark is eligible for 180 days of CGT exclusivity upon development.
This is Glenmark’s 1st granted CGT product approved by the fda.
Company's current portfolio consists of 145 product approved for distribution within the US marketplace and 55 ANDA’s unfinished approval with the USFDA.
In addition to those internal filings, Glenmark continues to spot and explore external development partnerships to supplement and accelerate the expansion of its existing pipeline and portfolio.
At 09:50 hrs Glenmark pharma was quoting at Rs 691.90, up Rs 25.50, or 3.83 % on the bse.
For more detail Just Call : 6232995233
Visit : www.TheGRSsolution.com
